TATp |
Superparamagnetic iron oxide particle [96,97] |
CD34+ cells |
For intracellular labeling, MRI, magnetic separation of homed cells, cell imaging |
TATp |
Liposomes [98–100] |
Mouse NIH/3T3 fibroblasts, human BT20 cells, and rat H9C2, U-87 MG cells |
To show the potential of TAT-liposome for intracellular delivery, and the intracellular gene delivery in vitro and in vivo
|
TATp |
SLN [101] |
Bronchial epithelial cells and mice |
To optimize gene transfer and offer the opportunity for further studies in large animal models |
TATp |
PEI-PEG conjugate [103] |
A459 cells and mice |
A new approach to non-viral gene carriers for lung therapy, comprising protection for plasmid DNA, low toxicity and significantly enhanced transfection efficiency under in vivo conditions |
TATp |
PEI-β-CyD conjugate [104] |
Placental mesenchymal stem cells (PMSCs) |
To improve the transfection efficiency to PMSCs |
NLS |
DOTAP:DOPE (1:1 w/w) liposome [105] |
SKnSH mammalian neuroblastoma cells |
To improve the efficiency and efficacy of non-viral methods of gene therapy |
NLS |
pH sensitive liposome [106] |
Rat peritoneal macrophages |
To deliver bovine serum albumin into the nucleus |
NLS |
Cobalt(II)-polybenzimidazole [107] |
Various cell lines |
To enhance expression of the transgenes |
DBP (NF-κB) |
PLGA/PEI nanospheres [108] |
COS7 cells and human monocyte-derived dendritic cells |
To enhance intracellular transport |
DBP(HMG-1) |
Linear PEI and branch PEI-based nano-particles [109,110] |
Mammalian cells |
To improve their gene transfer efficiency by non-viral carriers with peptides |
DEX |
PEI-based nanoparticles [112] |
HepG2 cells, 293 cells |
To increase the membrane perturbation and transfection efficiency |
DEX |
HA-PEI [114,115] |
B16F10 cells and tumor-bearing nude mice |
For double level targeted gene delivery with DNA ternary complexes |
ATRA |
PEI [118] |
NIH3T3 cells, HeLa cells |
To evaluate the nuclear translocation of ATRA-enriched nanoparticles |
ATRA |
Cationic liposome [119] |
A mouse of metastatic lung tumor |
For lung therapy |
CaP |
Asymmetric liposome with a CaP core [120–122] |
H460 cells, B16F10 cells and mice |
To increase the cargo delivery and release activity |
CR8C |
Cationic liposomes with a CaP core [125] |
Mouse liver |
To deliver pDNA to the nuclei of mouse hepatocytes |